I think that's clearly what happened. you just have to look at what was happening to Sarepta at the time. Something about toxicity (probably due to high volume of product delivered), less than expected effectiveness and SP halving...Sarepta were in damage control. their loss. Now it seems Audentes have a couple of drugs targeting DMD in their pipeline. its hotting up. Imagine if PYCtx were able to deliver Sarepta's DMD drug (far)more effectively to eliminate/reduce toxicity - that would wake them up.
Ann: Drug Delivery Greater Than 100% More Effective In Animals, page-35
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $559.9M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 12.5¢ | 12.0¢ | $185.3K | 1.515M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 166662 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 39575 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PYC (ASX) Chart |